Agree, and even if it is a month later - so what. God knows I have waited a long time and this is clear evidence they are foot to the floor.
The Healey trial platform design changes were only finalised days ago and IND in already.
The content of the IND is comprehensive so much of the heavy lifting is either done or very advanced and about to be done.
@@Densy also shared a link about not over hyping and over promising. Under promise/overdeliver is significantly more credible to the scientific community and also the ALS community.
See if Micheal can smash out one more before the end of the week. OMPD? Maybe! Something else? Maybe!
If the preclinical keeps going the way it is for ALS and once the Regimen H (NUZ-001) is up in lights on the Healey/Neals/ IM ALS/etc websites - I do feel we will be in a very strong position of discussions prior to interim results.
If preclinical shows strong indications in another disease then that opens all sorts of conversations because all the big ones have big charities all striving for something that turns their corner. But they will know - we have an ALS focus but hey, money talks.
I am having a good day today / good week this week. I know it is a little sugar rush but what the heck.
Even if the SP is not what I would like, I said to another long term player yesterday, I didn't sell in the 30c or 40c or 50c range so it would be just a warm and fuzzy rather than a genuine celebration & realisation of my strategic outcome (whatever it ends up being).
adreamer
NUZ Price at posting:
17.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)